Investor Relations

Latest Presentations

Recent Events

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2019

Company Overview

Codexis, Inc. (Nasdaq: CDXS) is a leading protein engineering company that applies its technology to the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. Codexis' proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing..

Investor Contact Information

Company

Codexis, Inc.
200 Penobscot Drive
Redwood City, CA 94063

Investor Relations

Codexis, Inc.
200 Penobscot Drive
Redwood City, CA 94063
T: 650-421-8106
ir@codexis.com

Transfer Agent

EQ Shareowner Services
1110 Centre Pointe Curve
Suite 101
Mendota Heights, MN 55120-4100
T: 800-468-9716
www.shareowneronline.com

Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Back To Top
Close search
Search